On July 29, 2025, iBio, Inc. received a notice from Nasdaq, stating that its stock did not meet the minimum closing bid price requirement of $1.00 per share, but it has until January 26, 2026, to regain compliance. The notice does not immediately affect the stock's listing, which will continue to trade under the symbol 'IBIO'.